Zobrazeno 1 - 10
of 462
pro vyhledávání: '"antiangiogenic inhibitors"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Luo, Kaixiu, Bao, Yafeng, Liu, Feifei, Xiao, Chuanfan, Li, Ke, Zhang, Conghai, Huang, Rong, Lin, Jun, Zhang, Jihong, Jin, Yi
Publikováno v:
In European Journal of Medicinal Chemistry 1 October 2019 179:805-827
Autor:
Ma, Jie-Tao1 (AUTHOR), Guo, Yi-Jia1 (AUTHOR), Song, Jun1 (AUTHOR), Sun, Li1 (AUTHOR), Zhang, Shu-Ling1 (AUTHOR), Huang, Le-Tian1 (AUTHOR), Jing, Wei1 (AUTHOR), Zhao, Jian-Zhu1 (AUTHOR), Han, Cheng-Bo1 (AUTHOR)
Publikováno v:
BioMed Research International. 1/28/2021, p1-15. 15p.
Autor:
Shen, Wanji1,2 (AUTHOR), Jin, Ying2 (AUTHOR), Yu, Ying2,3 (AUTHOR), Chen, Ning2,3 (AUTHOR), Fan, Yun2 (AUTHOR) fanyun@zjcc.org.cn
Publikováno v:
Thoracic Cancer. Jan2024, Vol. 15 Issue 2, p122-130. 9p.
Autor:
Salman Akhtar, Neha Sharma, Mala Sharma, Mohammad Faisal, Abdulrahman A. Alatar, Rajnish Kumar, Saheem Ahmad
Publikováno v:
Letters in Drug Design & Discovery. 20:95-109
Background: HSP90, a critical molecular chaperone, has become a promising molecular target to be involved in multiple signaling pathways of tumor progression and metastasis. Objective: This study intends to find a novel phytolead targeting HSP90. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3031ddd2c124fe8f05da8f5cb2cf4fdc
https://doi.org/10.2174/1570180819666220921165802
https://doi.org/10.2174/1570180819666220921165802
Publikováno v:
Клиническая практика, Vol 15, Iss 2, Pp 20-28 (2024)
BACKGROUND: Antiangiogenic treatment of diabetic macular edema is a first-line therapy in modern ophthalmology. Novel antiangiogenic drugs are increasingly being developed to improve treatment results and solve certain issues. However, owing to the a
Externí odkaz:
https://doaj.org/article/3d4cad75ae4e4320b380581c058f8351
Publikováno v:
Thoracic Cancer, Vol 15, Iss 2, Pp 122-130 (2024)
Abstract Background Thymic epithelial tumors (TETs) are rare malignant tumors with limited treatment options. No established second‐line treatment regimen is available following the preferred first‐line chemotherapy, resulting in unsatisfactory e
Externí odkaz:
https://doaj.org/article/2cef7ed24876482cb09c856e11d2cd76
Autor:
Wei Jing, Yi-Jia Guo, Le-Tian Huang, Jian-Zhu Zhao, Li Sun, Jun Song, Jie-Tao Ma, Cheng-Bo Han, Shu-Ling Zhang
Publikováno v:
BioMed Research International, Vol 2021 (2021)
BioMed Research International
BioMed Research International
Purpose. A meta-analysis of randomized controlled trials (RCTs) was conducted to compare the difference in efficacy and safety between epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) with antiangiogenic inhibitors ( A + T ) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4159902409e22558e2472af3dd9e884
https://doaj.org/article/46ba90c7cd1c4a3f86aaf1d9f9c9cd75
https://doaj.org/article/46ba90c7cd1c4a3f86aaf1d9f9c9cd75
Autor:
Jun Lin, Conghai Zhang, Kaixiu Luo, Feifei Liu, Jihong Zhang, Yafeng Bao, Chuan-Fan Xiao, Rong Huang, Yi Jin, Ke Li
Publikováno v:
European Journal of Medicinal Chemistry. 179:805-827
A novel series of benzylidene-succinimide derivatives were synthesized, characterized and evaluated for their cytotoxicities against HCT116, and SW480 cancer cells and NCM460 normal human cells. Their antiangiogenic capabilities were evaluated using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e58ee79e409a3df313676350fdb24a
https://doi.org/10.1016/j.ejmech.2019.06.094
https://doi.org/10.1016/j.ejmech.2019.06.094
Autor:
Javaherian, Kashi1, Lee, Tong-Young2, Sjin, Robert M. Tjin Tham2, Parris, George E.1, Hlatky, Lynn1
Publikováno v:
Dose-Response. 2011, Vol. 9 Issue 3, p369-376. 8p.